AU7411601A - Solid, orally administered, water-dispersible pharmaceutical form for the treatment of tuberculosis, containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, method for obtaining and presentation form of said pharmaceutical form - Google Patents
Solid, orally administered, water-dispersible pharmaceutical form for the treatment of tuberculosis, containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, method for obtaining and presentation form of said pharmaceutical formInfo
- Publication number
- AU7411601A AU7411601A AU74116/01A AU7411601A AU7411601A AU 7411601 A AU7411601 A AU 7411601A AU 74116/01 A AU74116/01 A AU 74116/01A AU 7411601 A AU7411601 A AU 7411601A AU 7411601 A AU7411601 A AU 7411601A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical form
- pirazinamide
- isoniazid
- tuberculosis
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229960003350 isoniazid Drugs 0.000 title 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 title 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 title 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 title 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 title 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 title 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 title 1
- 229960001225 rifampicin Drugs 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200001483 | 2000-06-13 | ||
| ES200001483A ES2184561B1 (en) | 2000-06-13 | 2000-06-13 | SOLID PHARMACEUTICAL FORM OF ORAL DISPERSABLE ADMINISTRATION IN WATER FOR THE TREATMENT OF TUBERCULOSIS CONTAINING RIFAMPYCIN, ISONIAZIDE, PYRAZINAMIDE AND HYDROCHLORINE PYRIDOXINE, PROCEDURE FOR OBTAINING AND FORM OF PRESENTATION FORCES. |
| PCT/ES2001/000241 WO2001095887A1 (en) | 2000-06-13 | 2001-06-12 | Solid, orally administered, water-dispersible pharmaceutical form for the treatment of tuberculosis, containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, method for obtaining and presentation form of said pharmaceutical form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7411601A true AU7411601A (en) | 2001-12-24 |
Family
ID=8493880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU74116/01A Abandoned AU7411601A (en) | 2000-06-13 | 2001-06-12 | Solid, orally administered, water-dispersible pharmaceutical form for the treatment of tuberculosis, containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, method for obtaining and presentation form of said pharmaceutical form |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7411601A (en) |
| ES (1) | ES2184561B1 (en) |
| WO (1) | WO2001095887A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2430724C2 (en) * | 2009-09-16 | 2011-10-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Coformulated antituberculous drug |
| CN101785771A (en) * | 2010-03-05 | 2010-07-28 | 张徐红 | Compound isoniazid tablet |
| FR2963236B1 (en) * | 2010-07-28 | 2013-03-01 | Pharma 5 Lab | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING RIFAMPICIN, ISONIAZIDE, PYRAZINAMIDE AND, IF POSSIBLY, ETHAMBUTOL |
| WO2012013756A2 (en) * | 2010-07-28 | 2012-02-02 | Laboratoires Pharma 5 | Method for preparing tablets combining rifampicin, isoniazid, pyrazinamide and, optionally, ethambutol |
| CN103816545A (en) * | 2013-10-30 | 2014-05-28 | 安徽万邦医药科技有限公司 | Pharmaceutical composition containing rifampicin and sodium dodecyl sulfate |
| WO2015107375A1 (en) | 2013-12-20 | 2015-07-23 | Vergara Campillo Ramiro Moises | Combination of pyridoxine, folic acid and magnesium ions for treating cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3784553A (en) * | 1972-01-17 | 1974-01-08 | Made Labor Sa | Pyridoxine alpha-ketoglutarate and its derivatives |
| IT1289883B1 (en) * | 1996-10-09 | 1998-10-19 | Lupin Lab Ltd | ANTI-TUBERCULAR PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PRODUCTION |
| RO114406B1 (en) * | 1997-12-12 | 1999-04-30 | Univ De Vest Vasile Goldis | Drug for treating tuberculosis and process for preparing the same |
-
2000
- 2000-06-13 ES ES200001483A patent/ES2184561B1/en not_active Expired - Fee Related
-
2001
- 2001-06-12 WO PCT/ES2001/000241 patent/WO2001095887A1/en active Application Filing
- 2001-06-12 AU AU74116/01A patent/AU7411601A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001095887A1 (en) | 2001-12-20 |
| ES2184561B1 (en) | 2003-12-16 |
| ES2184561A1 (en) | 2003-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003064431A3 (en) | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | |
| AU2001230892A1 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same | |
| NZ514574A (en) | Novel method of treatment | |
| WO2003002136A3 (en) | Stable formulation of modified glp-1 | |
| AU6406299A (en) | Methods and apparatus for improved administration of pharmaceutically active compounds | |
| EP1020460A3 (en) | The sodium salt of the (-)-enantiomer of omeprazole | |
| AU2001231000A1 (en) | Dry powder formulations of antihistamine for nasal administration | |
| ZA200603538B (en) | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
| NO20064010L (en) | Indazole derivatives and pharmaceutical preparations contain such | |
| AU2002236647A1 (en) | Method and device for administering medication and/or placebo | |
| AU7079700A (en) | Improved stable formulations of ace inhibitors, and methods for preparation thereof | |
| WO2003028715A3 (en) | Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis | |
| AU2003293593A1 (en) | Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration | |
| MY118569A (en) | Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates | |
| WO2002007721A3 (en) | Use of cox-2 inhibitors for preventing immunodeficiency | |
| ZA966163B (en) | Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives. | |
| WO1999033450A3 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
| WO2001032631A3 (en) | Heterocyclic cytotoxic agents | |
| AU7411601A (en) | Solid, orally administered, water-dispersible pharmaceutical form for the treatment of tuberculosis, containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, method for obtaining and presentation form of said pharmaceutical form | |
| WO2001081316A3 (en) | Substituted phenyl farnesyltransferase inhibitors | |
| WO2002012198A3 (en) | 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods | |
| AU2001230898A1 (en) | Formulations and methods for administration of pharmacologically or biologicallyactive compounds | |
| WO2000048445A3 (en) | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence | |
| WO2004012722A3 (en) | Bicifadine formulation | |
| AU6605100A (en) | Method and pharmaceutical composition for parenteral administration of iron |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |